Robin K Kelley Selected Research

Robin K Kelley Research Topics

Disease

26	Neoplasms (Cancer) 01/2023 - 03/2008
24	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 12/2008
8	Cholangiocarcinoma 01/2023 - 05/2012
4	Disease Progression 01/2023 - 10/2015
4	Colorectal Neoplasms (Colorectal Cancer) 12/2019 - 01/2011
3	Fatigue 01/2023 - 07/2018
3	Liver Neoplasms (Liver Cancer) 01/2023 - 11/2019
3	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2018
3	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 10/2012
3	Carcinoma (Carcinomatosis) 12/2019 - 10/2012
2	Diarrhea 01/2020 - 07/2018
2	Neutropenia 11/2019 - 01/2019
2	Thrombocytopenia (Thrombopenia) 11/2019 - 01/2019
2	Fibrosis (Cirrhosis) 10/2019 - 01/2019
2	Pancreatic Neoplasms (Pancreatic Cancer) 10/2015 - 03/2008
2	Liver Diseases (Liver Disease) 03/2015 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 06/2011 - 01/2011
1	Stomatitis 01/2023
1	Hyperphosphatemia 01/2023
1	Paralysis (Palsy) 01/2022
1	Stroke (Strokes) 01/2021
1	Ascites 01/2020
1	Inflammation (Inflammations) 10/2019
1	Melanoma (Melanoma, Malignant) 03/2019
1	Hypoalbuminemia 01/2019
1	Embolism (Embolus) 01/2019
1	Hypertension (High Blood Pressure) 07/2018
1	Multiple Myeloma 10/2015
1	Carcinogenesis 04/2015

Drug/Important Bio-Agent (IBA)

8	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
8	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 12/2008
5	cabozantinibIBA 01/2022 - 04/2015
4	LY-2157299IBA 01/2021 - 01/2019
4	Phosphotransferases (Kinase)IBA 01/2019 - 10/2015
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2011
3	Gemcitabine FDA Link 12/2019 - 03/2008
2	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2023 - 07/2018
2	futibatinibIBA 01/2023 - 01/2019
2	TOR Serine-Threonine KinasesIBA 11/2021 - 10/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 04/2015
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 01/2019
2	PlatinumIBA 12/2019 - 11/2017
2	Cell-Free Nucleic AcidsIBA 10/2019 - 10/2015
2	NivolumabIBA 03/2019 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 03/2015
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Fetal Proteins (Fetoprotein)IBA 01/2023
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 01/2023
1	cyclopropapyrroloindoleIBA 01/2022
1	CytokinesIBA 01/2022
1	temsirolimus FDA Link 11/2021
1	thiamine triphosphorate (TTP)IBA 11/2021
1	RamucirumabIBA 01/2021
1	enzalutamideIBA 12/2020
1	Androgen Receptors (Androgen Receptor)IBA 12/2020
1	B7-H1 AntigenIBA 10/2020
1	pembrolizumabIBA 10/2020
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2020
1	Bevacizumab (Avastin)FDA Link 01/2020
1	regorafenibIBA 01/2020
1	atezolizumabIBA 01/2020
1	ivosidenibIBA 01/2020
1	hydroxide ionIBA 12/2019
1	25-hydroxyvitamin DIBA 12/2019
1	Vitamin D FDA LinkGeneric 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 03/2019
1	gallium 68 PSMA-11IBA 03/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	CH5183284IBA 01/2019
1	BilirubinIBA 01/2019
1	alpha-Fetoproteins (alpha-Fetoprotein)IBA 01/2019
1	TKM-080301IBA 01/2019
1	Polo-Like Kinase 1IBA 01/2019
1	infigratinibIBA 01/2019
1	Transforming Growth Factor-beta Type I ReceptorIBA 01/2019
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019
1	Tyrosine (L-Tyrosine)FDA Link 07/2018
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2018
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 01/2018
1	talazoparibIBA 11/2017
1	Carboplatin (JM8)FDA LinkGeneric 11/2017
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2015
1	MTOR InhibitorsIBA 10/2015
1	CC-223IBA 10/2015
1	Circulating Tumor DNAIBA 10/2015
1	Mechanistic Target of Rapamycin Complex 2IBA 10/2015

Therapy/Procedure

16	Therapeutics 09/2023 - 03/2008
6	Drug Therapy (Chemotherapy) 01/2023 - 03/2008
4	Immunotherapy 01/2023 - 06/2015
2	Precision Medicine 10/2015 - 01/2011
2	Liver Transplantation 05/2012 - 01/2012
1	Aftercare (After-Treatment) 12/2019
1	Radiotherapy 01/2018
1	Semiconductors 03/2015